Neurofunctional Pain Management® As A Solution To Healthcare Costs And The Opioid Crisis
Neurofunctional Pain Management® is a non-pharmaceutical, non-surgical, non-invasive, and non-chiropractic pain management program. Patients who receive Neurofunctional Pain Management® treatment for chronic pain conditions may be able to avoid opioids and reduce or even eliminate the need for surgery, invasive procedures, and implants.
In addition to reducing the need for expensive and invasive procedures, Neurofunctional Pain Management® is engaging in health restoration efforts to get patients into a better state of health altogether.
This therapy may be able to slow the progression of current conditions and delay the onset of additional metabolic conditions, and in some cases reduce or eliminate current medical problems associated with poor health and lifestyle. Together, this can help ease pressure on the healthcare system and tackle ballooning healthcare costs.
Electroanalgesia: An FDA Cleared Treatment for Chronic Pain
Electroanalgesia is the first component of Neurofunctional Pain Management®. Electroanalgesia is a FDA Cleared treatment where a specific area is electrically stimulated with a range of electrical pulses to relieve pain.
Electroanalgesia can only be delivered by trained physicians with authorized devices – nearly all other electrical stimulation devices are not authorized to perform this high pulse range.
The pain relieving effect that occurs in the tissue, particularly in the pain neurons, is called sustained depolarization. In effect, the pain neurons become acclimated to a new homeostasis of being unpolarized and not reporting pain, creating a new normal of non-pain.
This also serves to reduce inflammation triggered by pain reporting neurons, thereby reducing the inflammation associated with pain conditions in a positive feedback loop. This positive feedback loop means reduced pain leads to reduced inflammation, which leads to reduced pain and so on.
The term for using high pulse electrical stimulation and electroanalgesia to reduce inflammation is called Electroionic® inflammation reduction or Electroionic® Therapy.
Electroanalgesia is an effective pain relief treatment that can endure even after the treatment has concluded. The duration of pain relief is related to the sustained depolarization effect that accumulates over multiple treatments.
For instance, a single treatment may last a few hours to a few days, whereas a course of regular treatments over several weeks can endure for months after completion. This is the reason longer treatment courses are recommended, preferably with multiple treatments occurring each week to obtain the desired cumulative pain relief effect.
Neuragenex®® protocols consist of two electroanalgesia treatments per week for twelve weeks, accompanied by a routine series of hydration therapy. This treatment combination and duration helps to create a relatively long-term pain relief effect that may last longer than most other methods of pain relief.
It has been a common occurrence for patients to experience relief for several months or even up to a year or more after completing their treatment. I have personally seen many patients experience long-term pain relief from a variety of chronic pain conditions, where the relief lasted over a year with no additional treatments or medications to prolong the effect.
Electroanalgesia is a specific and recognized medical term that is based on the electrical pulse per second capacity of the device used for the treatment, set according to the FDA clearance to perform that level of high pulsation.
Though many devices could be configured to reach the therapeutic pulse per second ranges of electroanalgesia, they are not authorized to be sold in the market in this manner. Extensive device trials are required for true FDA device approval in this treatment category, and to claim the ability to use the term electroanalgesia as a provider.
FDA device clearance for electroanalgesia is also required for Medicare and commercial insurance reimbursements, so any non-physician providers offering cash only treatments likely aren’t using a true electroanalgesia treatment or device.
Additionally, there is widespread confusion over what is, and what is not, an appropriate FDA cleared device for electroanalgesia treatment. Neurofunctional Pain Management® only uses 510k approved electroanalgesia devices that are FDA cleared for high pulse level therapy.
Electroanalgesia devices are allowed to modulate their cycles below electroanalgesia frequencies and back up, however other lesser devices are not allowed to do this. Instead, they must stay in the low power low pulse per second ranges where they are allowed
For example, transcutaneous electrical nerve stimulation (TENS) devices are low power low pulse devices that are not able to deliver Neurofunctional Pain Management® as a TENS unit is not capable of reaching the pulse per second frequencies that qualify as electroanalgesia settings by the FDA.
Patients will often claim that they had a “similar” electrical treatment from their chiropractor or physical therapist. However, unless there was a genuine medical provider supervising the treatment, these are most likely low level TENS unit treatments that are not able to perform true electroanalgesia therapy.
In an attempt to circumvent the prohibited use of the official term electroanalgesia, which is not allowed to be used to describe TENS treatment, non-physician providers and device manufacturers have obfuscated the industry with other terms that are not recognized but which sound like high-tech medical terms.
Some of the terms used to circumvent the term electroanalgesia include electrical cell signaling, quantum specific resonance, frequency therapy, frequency healing, resonance therapy, and a variety of other terms using high-tech sounding words like quantum, frequency, and resonance.
While these terms attempt to create mystery, depth, and significance, hoping to drive sales to unsuspecting patients, the devices are still only classified as TENS units by the FDA.
The rubber meets the road when non-physician providers attempt to use these devices for reimbursement with Medicare or other commercial insurance companies, only to be denied and blocked by these payers as the devices and mysterious terminology are simply TENS units being described as something other than what they are.
Though non-physician providers using TENS units will heavily advocate that their treatment is “identical” or “the same as” true electroanalgesia treatments, they are not the same, nor do they produce the same effect, nor are they recognized by the FDA as electroanalgesia devices with 510k FDA certifications.
If your non-physician provider is claiming to offer a Neurofunctional Pain Management® treatment program, simply know that non-physician providers are not allowed to practice Neurofunctional Pain Management® as it is beyond their scope of practice. Instead, only seek authorized service providers of Neurofunctional Pain Management®. This is your first step in starting in the right place.
Specialized Nutritional Hydration Therapy
Restoring health through nutritional deficiency hydration IV therapy is the second component of Neurofunctional Pain Management®. This process starts with a thorough evaluation of the patient’s blood work, identifying nutritional deficiencies in vitamins, minerals, and other core nutritional components. Once a thorough evaluation is performed and the nutritional deficiencies are identified, patients will receive a routine course of IV hydration therapy for intensive health restoration.
This hydration therapy protocol has a synergistic effect with the electroanalgesia therapy that is offered concurrently, as both therapies produce an anti-inflammatory effect in different manners. The combination of these two therapies produces an enduring pain relief effect that may last for several months after treatment has completed.
As a result, a chronic pain patient could experience months and months of pain relief with no additional therapy after completing a course of treatment under a Neurofunctional Pain Management® protocol.
Chronic inflammation is characterized by a concentration of hydrogen ions in specific tissues or areas. Inflamed tissues have a higher concentration of hydrogen ions, resulting in a lower pH in the tissue. Hydration therapy can help reduce inflammation through hydrogen ion diffusion of the inflamed tissues.
For example, if you have too much salt in your water then it’s much easier to add more water and dilute the salt than it is to try to extract the salt and reduce the saltiness of the water. For this reason, hydration therapy serves as an inflammation reduction therapy, called Hydroionic® inflammation reduction or Hydroionic® Therapy.
The combination of Electroionic® and Hydroionic® therapy results in a synergistic effect that is termed Hydroelectric® Therapy. Though the term Hydroelectric® is heavily associated with dams and rivers, it is a perfect description of the combination of these two therapy components of Neurofunctional Pain Management®.
Both therapies work together to relieve chronic systemic inflammation and produce an ongoing pain relief effect for patients suffering from chronic pain.
Better Outcomes With Neurofunctional Pain Management®
Neurofunctional Pain Management® is more than just pain relief. It is a concerted effort to restore health and improve quality of life for patients suffering from chronic pain conditions. Neuragenex®® is continuing to refine the treatment protocols to improve the program and expand this new field of medicine across the nation.
The mission of Neuragenex®® is to relieve pain, restore health, and magnify quality of life without drugs, surgery, or invasive procedures. The ultimate goal of Neuragenex®® is to be the first choice in the journey of alleviating chronic pain. Healthcare would look quite different if Neurofunctional Pain Management® was the starting point for chronic pain conditions.